ECM
TMO icon

Endurant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Endurant Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,794
Closed -$2.01M – 23
2023
Q4 		$2.01M Sell
3,794
-10,055
-73% -$4.87M 11.55% 2
2023
Q3 		$7.01M Buy
+13,849
New +$7.38M 6.3% 2
2023
Q2 		– Sell
-3,744
Closed -$2.16M – 58
2023
Q1 		$2.16M Buy
3,744
+2,155
+136% +$1.21M 1.11% 26
2022
Q4 		$875K Buy
+1,589
New +$842K 0.36% 39
2021
Q3 		– Sell
-29,679
Closed -$15M – 64
2021
Q2 		$15M Buy
+29,679
New +$14M 4.12% 5
2019
Q2 		– Sell
-10,500
Closed -$2.87M – 76
2019
Q1 		$2.87M Buy
+10,500
New +$2.61M 1.14% 27
2018
Q3 		– Sell
-3,407
Closed -$706K – 84
2018
Q2 		$706K Sell
3,407
-20,401
-86% -$4.33M 0.31% 52
2018
Q1 		$4.92M Sell
23,808
-19,800
-45% -$4.16M 1.84% 19
2017
Q4 		$8.28M Sell
43,608
-16,000
-27% -$3.07M 2.53% 14
2017
Q3 		$11.3M Sell
59,608
-33,000
-36% -$5.98M 3.42% 7
2017
Q2 		$16.2M Buy
92,608
+53,922
+139% +$9.06M 4.57% 1
2017
Q1 		$5.94M Buy
38,686
+2,200
+6% +$336K 1.91% 20
2016
Q4 		$5.15M Buy
36,486
+15,800
+76% +$2.33M 2.13% 20
2016
Q3 		$3.29M Sell
20,686
-31,000
-60% -$4.78M 1.22% 29
2016
Q2 		$7.64M Sell
51,686
-1,800
-3% -$266K 2.55% 12
2016
Q1 		$7.57M Buy
53,486
+11,341
+27% +$1.52M 2.45% 12
2015
Q4 		$5.98M Sell
42,145
-79,429
-65% -$10.6M 2% 17
2015
Q3 		$14.9M Buy
121,574
+12,624
+12% +$1.64M 4.96% 2
2015
Q2 		$14.1M Buy
108,950
+4,700
+5% +$613K 4.17% 4
2015
Q1 		$14M Sell
104,250
-16,700
-14% -$2.15M 4.63% 3
2014
Q4 		$15.2M Buy
+120,950
New +$14.7M 5.95% 1

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Endurant Capital Management's TMO Position: Q1 2024 in Review

Endurant Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 3,794 shares — an estimated $2.01M sold.

Endurant Capital Management first reported a position in TMO in Q4 2014 and held it in 21 quarters. The position peaked at $16.2M in Q2 2017. 2,528 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Endurant Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 3,794 Thermo Fisher Scientific shares in Q1 2024, an estimated $2.01M.
  • Endurant Capital Management first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 21 quarters.
  • Endurant Capital Management's Thermo Fisher Scientific position peaked at $16.2M in Q2 2017.
  • 2,528 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.